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Abstract Incorporation of L-13SS]cysteine into rabbit muscle 
glyceraldehyde-3-phosphate dehydrogenase was detected follow- 
ing incubation of the enzyme in a mixture containing glyceralde- 
hyde-3-phosphate, NAD ÷ and the labeled cysteine. Insignificant 
binding occurred in the absence of either the substrate or NAD ÷, 
suggesting that formation of an acylated enzyme form was a 
prerequisite for the binding. Stoichiometry of the binding de- 
pended on the number of functioning active centers; up to 4 moles 
of L-[3SS]cysteine bound per mole tetramer with fresh enzyme 
preparations. The L-[3SS]cysteine incorporation depended on pH 
and was maximal when a group having pK a of 8.5 is protonated. 
To clarify the relevance of this finding to the effect of SH- 
containing compounds previously shown to decrease the rate of 
3-phosphoglyceroyl-enzyme hydrolysis [Kuzminskaya et al., 
FEBS Lett. 336 (1993) 208-210], the pH-dependence of the effect 
of glutathione on the hydrolysis rate was determined and found 
to be close to the pH-dependence of L-[3SS]cysteine binding. 
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1. Introduction 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cat- 
alyzes a two-step reaction. First, glyceraldehyde-3-phosphate 
is oxidized to form a covalent intermediate at the essential 
Cys-149, complexed with NADH. Following NADH dissocia- 
tion from 3-phosphoglyceroyl-enzyme" NADH complex, 
NAI)  + binds to acyl-enzyme intermediate. The second step, 
phosphorolysis then occurs, yielding 1,3-biphosphoglycerate 
[2,3]. The replacement of NADH by NAD ÷ greatly accelerates 
the rate of acyl transfer to an acceptor-nucleophile [4,5], and 
this implies that specific, functionally important differences 
exist between the 3-phosphoglyceroyl-enzyme' NADH and 3- 
phosphoglyceroyl-enzyme.NAD + conformations. The struc- 
tural basis of these differences remains, however, unknown 
since no X-ray studies on the ternary complexes formed by 
GAPDH have been as yet performed. At the same time, infor- 
mation on the factors influencing conformational states of the 
acylated enzyme forms is of importance for better understand- 
ing the molecular mechanisms ofenzyme functioning and regu- 
lation. Such considerations warrant our interest as to the effect 
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of low molecular weight SH-containing compounds on the sta- 
bility of 3-phosphoglyceroyl-GAPDH intermediate r ported in 
our previous communication [1]. Significant deceleration f the 
acyl-enzyme hydrolysis observed in the presence of micromolar 
concentrations of cysteine, reduced glutathione or dithiothre- 
itol suggested that there is a specific interaction between the 
acylated enzyme and an effector. The purpose of this study was 
to experimentally test the ability of GAPDH to bind a low 
molecular weight SH-containing compound and to examine the 
correlation between the binding of the ligand and its effect. 
2. Materials and methods 
L-[35S]Cysteine as a hydrochloride (20-150 pCi/mmol) was obtained 
from Amersham. GAPDH was purified from rabbit skeletal muscle [6]. 
Immobilization of the enzyme was carried out as described [7] using 
CNBr-activated Sepharose 4B prepared before ach experiment (30 mg 
CNBr per 1 ml of the packed gel). Holoenzyme was dissolved in 0.1 M 
sodium phosphate, 5 mM EDTA, pH 8.3, protein concentration, 1.0- 
1.5 mg/ml. Under these conditions, 20C~500 pg protein per ml of the 
packed gel became immobilized (determined as described [8]). The 
binding of L-[35S]cysteine to the immobilized GAPDH was measured as
follows. Immobilized GAPDH was incubated with 2 mM DTT for 
1 h (or left overnight), washed with 100 vol. of a buffer with desired pH 
and suspended in the same buffer (1 ml of the buffer per 1 ml of the 
packed gel). The reaction mixture contained 0.2~).3 ml of the suspen- 
sion, 0.5 mM NAD ÷, 20/tM L-[35S]cysteine and 0.5 mM GAP. After 
the addition of the latter component and mixing, the gel was separated 
by centrifugation (10,000 ×g) for 1 min, and the radioactivity of the 
supernatants was determined. Controls lacking substrate were run in 
parallel. The amount of L-[3SS]cysteine corporated into the immobi- 
lized enzyme was estimated as the difference between the standard and 
control samples. 
3. Results 
The possibility that SH-containing compounds (e.g. cysteine 
and reduced glutathione) can specifically interact with 
GAPDH, was tested by measuring the binding of L-[35S]cysteine 
under the conditions resembling those employed in the studies 
on the effect of SH-containing compounds on the 3-phospho- 
glyceroyl-enzyme hydrolysis [1]. GAPDH immobilized on 
CNBr-activated Sepharose was used in these experiments. 
After incubation of the matrix-bound enzyme in an appropriate 
reaction mixture containing the label, the gel was quickly re- 
moved by centrifugation, and the supernatant was analyzed for 
the remaining L-[35S]cysteine. In this way, specific incorporation 
of the label into the enzyme could be followed owing to the fact 
that control samples which lacked but one component of the 
reaction mixture were run in parallel. As shown in Fig. 1, up 
to 4 moles of L-[35S]cysteine can be incorporated per tetrameric 
GAPDH in the presence of both GAP and NAD +. Curve 2 
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Fig. 1. The binding of [35S]cysteine to GAPDH immobilized on Sepha- 
rose 4B. Line 1 = 0.2 ml of the reaction mixture contained 30 mM 
HEPES-NaOH, pH 7.0, 5 mM EDTA, 0.5 mM NAD ÷, 0.5 mM GAP, 
1.0~0 /tM L-[35S]cysteine (0.015~).6 pCi) and 1 pM immobilized 
GAPDH tetramer. Line 2 = the same as line 1, but the immobilized 
enzyme was washed with 100 vols. of sodium phosphate buffer (30 
mM), pH 7.0, to remove bound NAD ÷. NAD ÷ was also omitted from 
the reaction mixture. Control samples contained all the components 
excepting GAP. Time of incubation (including centrifugation) did not 
exceed 5 min. The amount of the labeled cysteine incorporated in the 
enzyme was estimated from the decrease of L-[3SS]cysteine content in the 
supernatant ( he data obtained with the sample lacking GAP were 
subtracted from the data obtained with the sample containing GAP). 
refers to the sample where NAD ÷ was omitted from the reac- 
tion mixture. It is seen that the incorporation of the label is 
significantly reduced. Some binding was however detected, pos- 
sibly due to the presence of the firmly bound NAD + in the 
protein. In another experiment performed with an aged prepa- 
ration of the immobilized GAPDH, complete removal of 
NAD + has been achieved; in this case no binding of L-[3SS]cys- 
teine was detected in the absence of added NAD ÷. We have also 
observed that enzyme preparations not pretreated with DTT 
(see section 2) incorporated less L-[35S]cysteine (2.4 + 0.2 moles 
per mole tetramer). 
Taken together, the results obtained support he idea that the 
binding of L-[35S]cysteine depends on the integrity of essential 
Cys-149 and on the catalytic conversion of GAP into 3- 
phosphoglyceroyl-enzyme. The L-[3SS]cysteine incorporation 
into the protein might be a fast process; as shown in Fig. 2, the 
maximal effect was observed at the earliest ime of measure- 
ment possible in our experiments. As noted above, some bind- 
ing of L-[35S]cysteine occurred in the absence of GAP. This 
'non-specific' binding was normally subtracted from the meas- 
urements made using the complete reaction mixture. One can 
see from Fig. 2, curve 2, that the 'non-specific' binding progres- 
sively increased in time; incorporation of the cysteine into the 
matrix gel supporting the immobilized enzyme could partially 
account for the effect. Taking into consideration this time de- 
pendence of the 'non-specific' binding, we used the shortest 
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Fig. 2. Time dependence ofthe binding of L-[35S]cysteine to immobilized 
GAPDH. The experimental conditions were the same as in Fig. 1, 
L-[35S]cysteine concentration, 20/.tM. At a fixed time interval, the immo- 
bilized enzyme suspension was separated by centrifugation, and an 
aliquot (10/ll) of the supernatant was taken to determine the concentra- 
tion of L-[35S]cysteine. The remaining suspension was then mixed and 
the above procedure repeated. Line 1 -- the data obtained in the pres- 
ence of GAP minus the data obtained in the absence of GAP. Line 
2 = the data obtained in the absence of GAP. 
time of incubation possible under the conditions of our exper- 
iments. 
The binding of L-[3SS]cysteine to the enzyme exhibited is- 
tinctive pH dependence. As shown in Fig. 3, it is controlled by 
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Fig. 3. The binding of L-[35S]cysteine to immobilized GAPDH as a 
function of pH. 0.2 ml of the reaction mixture contained 50 mM 
HEPES-NaOH (pH 7.0-8.0), 50 mM sodium veronal-HCl buffer (pH 
8.0-8.5), or 50 mM glycine-NaOH buffer (pH 9.0-9.5), 5 mM EDTA, 
0.5 mM NAD ÷, 0.5 mM GAP, 20 pM L-[3SS]cysteine (0.3 pCi), 1 ~M 
tetramer GAPDH. See Fig. 1 for further details. 
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Fig. 4. pH-dependencies of the rate constants of 3-phosphoglyceroyl- 
enzyme hydrolysis performed in the absence (1) or in the presence (2) 
of 10/IM reduced glutathione. The reaction was carried out in 50 mM 
HEPES-NaOH (pH 7.0-8.5) or in 50 mM CHES-NaOH (pH 8.54.5), 
5 mM EDTA, 0.2 mM NAD +, 0.2 mM GAP, 8.5 pM soluble GAPDH 
and initiated by the addition of GAR 
an acidic group with pK, of 8.5. In view of these results, we 
were interested to investigate he pH dependence of the effect 
of SH-containing compounds on the hydrolysis of 3- 
phosphoglyceroyl-enzyme. As shown in our previous tudy [1], 
cysteine, reduced glutathione and DTT significantly decreased 
the rate of acyl-enzyme hydrolysis; in these experiments he 
reaction was carried out at pH 7.5. We thought hat if a corre- 
lation exists between the binding ofa SH-containing compound 
and its effect on hydrolysis, the pH dependence of the effect 
must be close to the pH dependence of the binding. The results 
shown in Fig. 4 argue in favour of this proposal. The inhibitory 
effect of reduced glutathione is maximal at pH 8 and disappears 
at pH above 9, i.e. displays apH-dependence closely resembling 
the pH-dependence of the binding of L-[35S]cysteine. 
4. Discussion 
The evidence we have presented supports the suggestion that 
GAPDH is capable of catalyzing the binding of a low molecular 
weight hiol. In fact, the effective binding of L-[35S]cysteine was 
only observed under the conditions where catalytic onversion 
of GAP into 3-phosphoglyceroyl-enzyme occurred. Similar re- 
sults were obtained in the absence or in presence of inorganic 
phosphate in the reaction medium, which implies that a single 
catalytic turnover yielding the acylated enzyme form was suffi- 
cient to ensure the binding. The extent of binding depended on 
the integrity of the essential Cys-149. With the fully active 
enzyme tetramer one mole of radiolabeled cysteine incorpo- 
rated per mole enzyme subunit; at present, we have no definite 
information on the mechanism ofthe process involved, and can 
only propose a hypothetical explanation for the findings. We 
speculate that upon acylation of the enzyme by its substrate, 
conditions are created for the activation of a low molecular 
weight hiol, necessary for its binding to the protein. The acti- 
vation might proceed through a nucleophilic attack of the cys- 
teine thiol group on the transition state acyl cation (which is 
suggested to appear after the binding of NAD ÷ to 3- phos- 
phoglyceroyl-enzyme [9]. A thioacetal formed in this way might 
serve as a source of a thiolate anion form of the cysteine trans- 
ferred to an appropriate acceptor, most likely a cysteine residue 
of the protein. Such an intramolecular transfer esulting in the 
formation of a mixed disulfide would strongly depend on the 
conformational state of the enzyme and might only be possible 
in the acylated enzyme form. Protonation of a group with pK a 
near 8.5 is also a prerequisite for the binding. A likely candidate 
for such a group is the SH-group of the cysteine in solution. 
Irrespective of the mechanism of cysteine incorporation, the 
modification alters functional properties of the enzyme. This is 
manifested in the decreased susceptibility of 3-phosphoglyc- 
eroyl-enzyme to hydrolysis. 
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